| |
|
|
| Name: |
SILVERARC CAPITAL MANAGEMENT LLC |
| City: |
BOSTON |
| State: |
MA |
| Zip: |
02116 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
30 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
MRUS |
Merus Nv |
1 |
- |
$45.85 |
$17,753,000 |
645,581 |
5.48% |
5,963,000 |
145,581 |
1.513 |
N/A |
|
|
MRSN |
Mersana Therapeutics, Inc. |
2 |
- |
$2.62 |
$14,895,000 |
6,420,136 |
4.59% |
8,545,000 |
1,420,136 |
5.728 |
N/A |
|
|
NUVL |
Nuvalent, Inc. |
4 |
- |
$0.00 |
$14,203,000 |
193,000 |
4.38% |
14,203,000 |
193,000 |
0.339 |
N/A |
|
|
PSTX |
Poseida Therapeutics, Inc. |
5 |
- |
$2.81 |
$12,451,000 |
3,705,779 |
3.84% |
3,959,000 |
137,794 |
5.994 |
N/A |
|
|
ORIC |
Oric Pharmaceuticals, Inc. |
10 |
- |
$0.00 |
$10,764,000 |
1,170,000 |
3.32% |
3,968,000 |
46,655 |
2.976 |
N/A |
|
|
CLDX |
Celldex Therapeutics Inc |
11 |
- |
$40.11 |
$9,805,000 |
247,215 |
3.02% |
9,805,000 |
247,215 |
0.472 |
Diagnostic Substances |
|
|
OLMA |
Olema Pharmaceuticals, Inc. |
12 |
- |
$0.00 |
$8,051,000 |
573,830 |
2.48% |
3,015,000 |
166,029 |
1.429 |
N/A |
|
|
URGN |
Urogen Pharma Ltd. |
14 |
- |
$13.07 |
$7,881,000 |
525,404 |
2.43% |
752,000 |
16,521 |
2.378 |
N/A |
|
|
XENE |
Xenon Pharmaceuticals Inc. |
15 |
- |
$0.00 |
$7,516,000 |
163,168 |
2.32% |
5,671,000 |
109,172 |
0.261 |
N/A |
|
|
VCYT |
Veracyte, Inc. |
16 |
- |
$22.50 |
$6,815,000 |
247,723 |
2.1% |
1,465,000 |
8,152 |
0.299 |
Biotechnology |
|
|
AKRO |
Akero Therapeutics, Inc. |
18 |
- |
$0.00 |
$5,820,000 |
249,254 |
1.79% |
4,235,000 |
217,918 |
0.496 |
N/A |
|
|
PLRX |
Pliant Therapeutics, Inc. |
19 |
- |
$0.00 |
$5,768,000 |
318,524 |
1.78% |
1,426,000 |
68,115 |
0.506 |
N/A |
|
|
COGT |
Cogent Biosciences, Inc. |
21 |
- |
$7.35 |
$5,684,000 |
966,748 |
1.75% |
-667,000 |
315,376 |
1.223 |
N/A |
|
|
TELA |
Tela Bio, Inc. |
25 |
- |
$5.80 |
$5,263,000 |
795,080 |
1.62% |
1,339,000 |
304,609 |
4.15 |
N/A |
|
|
CRBU |
Caribou Biosciences, Inc. |
28 |
- |
$3.71 |
$5,162,000 |
900,818 |
1.59% |
894,000 |
8,032 |
1.502 |
N/A |
|
|
SRRK |
Scholar Rock Holding Corp |
29 |
- |
$13.64 |
$5,076,000 |
270,000 |
1.57% |
5,007,000 |
260,289 |
0.523 |
N/A |
|
|
INSM |
Insmed Inc |
31 |
- |
$25.83 |
$4,819,000 |
155,504 |
1.49% |
1,022,000 |
5,117 |
0.103 |
Biotechnology |
|
|
SRPT |
Sarepta Therapeutics Inc |
32 |
- |
$131.70 |
$4,521,000 |
46,884 |
1.39% |
3,406,000 |
37,687 |
0.056 |
Drug Manufacturers - ... |
|
|
TERN |
Terns Pharmaceuticals, Inc. |
36 |
- |
$5.89 |
$3,355,000 |
516,999 |
1.03% |
840,000 |
16,999 |
0.927 |
N/A |
|
|
CERS |
Cerus Corp |
37 |
- |
$2.00 |
$3,240,000 |
1,499,851 |
1% |
1,290,000 |
295,961 |
0.897 |
Biotechnology |
|
|
BHVN |
Biohaven Ltd. |
39 |
- |
$33.78 |
$3,026,000 |
70,695 |
0.93% |
2,766,000 |
60,695 |
0.104 |
N/A |
|
|
MLTX |
Multisys Language Solutions... |
40 |
- |
$0.00 |
$3,020,000 |
50,000 |
0.93% |
3,020,000 |
50,000 |
0.122 |
N/A |
|
|
ZURA |
Zura Bio Ltd |
44 |
- |
$4.79 |
$2,162,000 |
462,997 |
0.67% |
-505,000 |
58,957 |
1.712 |
N/A |
|
|
ANNX |
Annexon, Inc. |
45 |
- |
$0.00 |
$1,895,000 |
417,429 |
0.58% |
952,000 |
17,713 |
0.485 |
N/A |
|
|
CGEN |
Compugen Ltd (USA) |
46 |
- |
$2.03 |
$1,861,000 |
940,000 |
0.57% |
1,535,000 |
589,812 |
1.134 |
Biotechnology |
|
|
ETNB |
89bio, Inc. |
48 |
- |
$8.70 |
$1,773,000 |
158,719 |
0.55% |
843,000 |
98,472 |
0.213 |
N/A |
|
|
NTLA |
Intellia Therapeutics, Inc. |
51 |
- |
$25.42 |
$1,672,000 |
54,822 |
0.52% |
-4,000 |
1,804 |
0.061 |
N/A |
|
|
SDGR |
Schrodinger, Inc. |
56 |
- |
$23.18 |
$1,114,000 |
31,117 |
0.34% |
257,000 |
806 |
0.055 |
N/A |
|
|
VRDN |
Viridian Therapeutics Ors Shs |
57 |
- |
$14.34 |
$1,099,000 |
50,438 |
0.34% |
371,000 |
3,000 |
0.111 |
N/A |
|
|
ALGS |
Aligos Therapeutics, Inc. |
61 |
- |
$0.00 |
$444,000 |
668,512 |
0.14% |
-28,000 |
36,625 |
1.908 |
N/A |
|
